---

Discussion

Sam Dewinski:

I would call it risk management before I called it a reset. The relationship carries a long security memory: the 1962 war, the unresolved Himalayan boundary and the deadly 2020 confrontation, when soldiers from both sides were killed. The 2024 patrol agreement and later disengagement created room for contact, but did not settle competing territorial claims. Meetings can resume without strategic trust returning.

Red Velhouse:

That history frames the economic question. Kate, how large and how unequal is the relationship?

Kate Burvish:

Very large, and sharply asymmetric. In India’s 2025–26 financial year, goods trade with China reached about 151.1 billion dollars. India imported roughly 131.63 billion and exported only 19.47 billion, producing a deficit of about 112.16 billion. These are merchandise figures, covering physical goods rather than the full exchange of services.

Red Velhouse:

What drives that deficit? Is it mainly consumer merchandise, or dependence built into Indian industry?

Kate Burvish:

It is primarily an industrial and technology story. In 2024–25, India’s largest named import category from China was electronic components, at about 36.8 billion dollars. Telecom instruments were about 22.3 billion; computer hardware and peripherals and industrial machinery were each about 18.5 billion. Other major categories included electrical machinery, chemicals, plastics and bulk drugs.

China therefore supplies components, equipment and industrial intermediates used by Indian factories, telecom networks, infrastructure projects and pharmaceutical producers.

Sam Dewinski:

The contrast is visible in the other direction. India’s exports to China have included iron ore, petroleum products, chemicals, shrimp, marine goods, castor oil and some engineering products. China sends machinery, electronics, computers, integrated circuits, telephone equipment, lithium-ion products and fertilizers.

The imbalance is therefore also about position in the production chain: India’s exports remain narrower and more concentrated in commodities and intermediates, while China exports a broader range of manufactured and technology-intensive goods.

Kate Burvish:

India’s industrial growth complicates the picture. Electronics production has expanded, but much assembly still depends on imported components. Indian electronics exports can rise while imports of Chinese parts rise too; gross exports are not the same as domestic value added.

Pharmaceuticals show the same tension. India exported about 25.8 billion dollars in pharmaceutical products in 2025 and is globally competitive in generic medicines. Yet it relies heavily on imported active pharmaceutical ingredients, or APIs—the chemicals that make medicines work. China supplied about 76.4 percent of India’s imports in one major API category.

Ann Tofado:

That dependence gives both governments reasons to engage and reasons to remain cautious. India wants affordable inputs for growth, but does not want critical dependence to become strategic leverage. China wants to preserve access to India’s large market and its role in regional supply chains.

A sudden cutoff would raise costs and disrupt Indian projects. Continued dependence, however, leaves India exposed if equipment, components, visas or approvals become politically sensitive.

Red Velhouse:

Does India simply lack products China wants, or is China’s market harder to enter than the deficit suggests?

Kate Burvish:

Both explanations matter. India has real export capabilities in generic pharmaceuticals, selected chemicals and APIs, engineering goods, marine products and agriculture. Its information-technology and business-services firms are also globally competitive, although China has not become a comparably large market for those services.

Global competitiveness does not automatically become competitiveness in China. Firms still need scale, certification, reliable supply, competitive prices, distribution and commercial relationships. In advanced electronics, semiconductors, high-end machinery, batteries and some complex pharmaceutical products, India remains less scaled than China.

Ann Tofado:

Access is another part of the explanation. The strongest documented barriers are often non-tariff measures: drug registration and procurement rules, technical standards, licensing, customs procedures, sanitary and phytosanitary rules for agriculture and seafood, and limited distribution channels.

India has obtained access for selected products, including rice, rapeseed meal, fish meal and fish oil, tobacco leaves and certain chili products. But a protocol for one product is not an open agricultural market. Inspection and certification still determine whether an exporter can sell at scale.

Sam Dewinski:

Pharmaceuticals illustrate the two-sided problem. An Indian government-commissioned study reported that Chinese registration could take three to four years, with disclosure requirements and, in some cases, clinical trials in China discouraging Indian firms. Those detailed findings are historical, so current rules may differ. They nevertheless document longstanding regulatory friction.

At the same time, Indian pharmaceutical production depends on Chinese APIs. India therefore has export capability, but not complete self-sufficiency or automatic access to China’s market.

Red Velhouse:

What, then, can BRICS actually do? Is it designed to balance trade between India and China?

Ann Tofado:

Not by requiring bilateral balance. BRICS promotes greater trade and investment among members. Its tools include customs cooperation, local-currency payments, possible payment platforms, investment facilitation, procurement cooperation and development finance through institutions such as the New Development Bank.

Those mechanisms can reduce transaction costs or finance projects. But BRICS documents do not create a bilateral quota, clearing arrangement or enforceable obligation requiring China to purchase a specified value of Indian goods. A payment system can make a transaction easier; it cannot create demand for a regulated or uncompetitive product.

Kate Burvish:

BRICS could still help with electronic agricultural certificates, digital documentation, customs dialogue and standards cooperation. For India’s deficit with China, however, bilateral work is more direct: drug approvals, agricultural protocols, recognition of testing, customs procedures, procurement access and distribution rights.

India and China already have a Joint Economic Group and sectoral working groups. Several have reportedly not met since 2019. Reviving them would be a more concrete signal than a general pledge to achieve balanced trade.

Sam Dewinski:

Historically, multilateral forums provide language and political cover, while difficult bargaining happens bilaterally. India and China maintained extensive commerce through years of disagreement, yet trade did not prevent the 2020 border crisis. BRICS can provide a shared stage, but it cannot settle the Himalayan boundary or substitute for functioning India–China negotiations.

Red Velhouse:

Could narrowing the deficit become a confidence-building measure, or would reducing dependence make the relationship more confrontational?

Kate Burvish:

It depends on what “reduce” means. Simply replacing Chinese machinery, components or APIs with more expensive alternatives could slow manufacturing and raise costs. A more durable strategy would increase domestic value added, diversify suppliers and expand exports at the same time.

India could build capacity in APIs, electronic components, machinery, batteries and solar inputs, while attracting investment that transfers capabilities rather than merely assembling products made from imported Chinese parts. That takes time and does not require abrupt economic separation.

Ann Tofado:

Market access should be negotiated product by product. India could seek faster and more transparent pharmaceutical approvals, clearer agricultural and seafood protocols, recognition of Indian testing, access to Chinese procurement and better distribution channels. China could reasonably ask for reliable supply and compliance with its standards.

A time-bound task force or revived working groups would be more meaningful than a promise to balance every invoice.

Ann Tofado:

The broader thaw remains guarded. India has selectively relaxed some restrictions on Chinese investment, particularly in electronics, capital goods and solar cells, while major proposed investments by BYD and Great Wall Motor have continued to face obstacles or uncertainty. India is trying to obtain technology and production capacity without abandoning security screening.

Reports also describe visa delays and difficulties involving equipment and components. Indian sources have cited customs delays affecting solar, electronics and infrastructure projects, while Chinese officials say visas are issued under applicable rules. These reports do not prove that every delay is deliberate leverage, but they show how dependence makes ordinary administration politically significant.

Red Velhouse:

The proposed connection between India’s Unified Payments Interface, or UPI, and Ant International’s Alipay Plus network raises the same question. What does it tell us?

Kate Burvish:

It shows the boundary between convenience and control. Connecting payment systems could help travelers and merchants, but it also raises questions about operational control, banking relationships, cybersecurity and data. Public reporting describes the proposal as delayed or under review, not permanently rejected.

Even a commercially attractive connection can therefore be assessed through a national-security lens.

Sam Dewinski:

That is why “economic cold war” is too simple. Some exchanges have resumed or eased, including direct flights and visa procedures for Chinese business professionals, while some Indian businesses still report difficulties. The better comparison is a guarded reopening after a crisis: doors open selectively, with someone still standing at each threshold.

Red Velhouse:

The two sides have also discussed de-escalation, additional border-management mechanisms and reopening three traditional border markets. Could those steps connect security normalization to commercial normalization?

Sam Dewinski:

They could, but only if the sequence holds. Border calm makes commercial contact less risky, and commercial contact can create constituencies for continued calm. Yet border markets are not a settlement, and resumed patrol practices do not resolve the boundary dispute. The test is durability, not ceremonial language.

Red Velhouse:

What should observers watch after Xi leaves New Delhi?

Kate Burvish:

Watch whether more Indian medicines are registered in China, whether agricultural and seafood protocols are implemented, whether customs becomes faster, and whether Indian firms win procurement contracts or expand distribution. On the import side, ask whether electronics assembly creates more domestic value or merely more demand for Chinese components. A smaller deficit achieved by slowing growth would not necessarily be a victory.

Ann Tofado:

And watch what both governments refuse to promise. India is unlikely to abandon security screening simply to improve trade figures. China is unlikely to accept every Indian demand for market access. The plausible outcome is not a grand bargain or automatically balanced BRICS trade, but a managed relationship: selective openings, continuing suspicion and cooperation where each side sees a clear advantage.

Red Velhouse:

The unresolved issue is whether the India–China thaw can move from diplomatic risk management to dependable commercial practice. The trade deficit is real, but its causes are not one-dimensional. China supplies India with electronics, telecom equipment, computers, machinery, chemicals and pharmaceutical inputs. India has genuine strengths in generic medicines, chemicals, engineering, agriculture, seafood and information-technology services, yet its exports to China remain narrower. Chinese regulatory and distribution barriers matter, while Indian firms also face limitations of scale, cost, supply chains and domestic value added.

BRICS can help with customs, payments, standards, investment and development finance. It is not an enforceable mechanism for balancing every member’s bilateral trade. The stronger tests will therefore be specific: product approvals, agricultural protocols, procurement access, customs clearance, investment that builds capability and continued border de-escalation. If those steps follow, the visit may mark cautious normalization. If not, it may remain a carefully managed pause in a deeper rivalry.

Sources and references for this discussion are
available with the episode at Factolio.com.

---

Sources and References

These sources supported the factual material used in this discussion. Factolio’s panel discussion is AI-generated from researched evidence and is written in original language.

1. Ministry of Foreign Affairs of the People’s Republic of China — Xi Jinping to attend the 18th BRICS Summit in India (PRIMARY)
2. Government of China / Xinhua — Xi to attend BRICS summit in India (PRIMARY)
3. Reuters, republished by MarketScreener — Xi’s India visit to help diplomatic thaw, but business ties bound by suspicion (NEWS)
4. Chinese Embassy / Ministry of Foreign Affairs — Foreign Ministry Spokesperson Mao Ning’s Regular Press Conference on September 11, 2026 (PRIMARY)
5. Associated Press — BRICS leaders gather in New Delhi as wars and rivalries strain the expanded bloc (NEWS)
6. Embassy of India, Beijing — Trade and Economic Relation (PRIMARY)
7. Business Today — UPI users may have to wait: India yet to decide on China’s Alipay+ integration (NEWS)
8. Press Information Bureau, Government of India — Statement by Raksha Mantri on India-China Border and Patrolling Restoration (PRIMARY)
9. Associated Press — India says it reached a pact with China on military patrols along their disputed border (NEWS)
10. Ministry of Foreign Affairs of the People’s Republic of China — Ten points of consensus for the 24th Round of Talks Between the Special Representatives of China and India on the Boundary Question (PRIMARY)
11. Ministry of Commerce and Industry, Government of India — Parliamentary data on India’s dependence on Chinese products and sectoral imports (PRIMARY)
12. Directorate General of Commercial Intelligence and Statistics / Indian Trade Journal — India’s Exports, Imports BoT with China, 2020–21 to 2024–25 (PRIMARY)
13. Press Information Bureau, Government of India — India’s Strategic Trade Ties: Top Merchandise Export Destinations (PRIMARY)
14. Department of Commerce, Government of India — TRADESTAT: Country-wise principal commodity data (PRIMARY)
15. Ministry of External Affairs, Government of India — Annual Report 2019–20 (PRIMARY)
16. NITI Aayog — Trade Watch Jan–Mar (Q4) FY 2025–26: Pharmaceutical and API trade analysis (PRIMARY)
17. Press Information Bureau, Government of India — Commerce Minister releases study report on Indian pharma exports to China (PRIMARY)
18. Ministry of Food Processing Industries, Government of India — Foreign Trade Policy statement: market-access issues in China’s pharmaceutical sector (PRIMARY)
19. Press Information Bureau, Government of India — India records strong seafood export performance in FY 2025–26 (PRIMARY)
20. NITI Aayog — Trade Watch: India’s services export performance (PRIMARY)
21. Ministry of Commerce and Industry, Government of India — Report of the High-Level Advisory Group on trade and economic relations (PRIMARY)
22. Institute for Studies in Industrial Development — India Industrial Development Report 2024–25: Towards a manufacturing-led transformation (ANALYSIS)
23. Ministry of Commerce and Industry, Government of India — Annual Report 2024–25: electronics, pharmaceuticals and manufacturing policy (PRIMARY)
24. World Trade Organization — India tariff and trade data profile (DATA)
25. BRICS Brazil Presidency — Areas of Cooperation (PRIMARY)
26. BRICS Brazil Presidency — BRICS approves Joint Declaration for fairer, more inclusive global trade (PRIMARY)
27. BRICS Brazil Presidency — Trade Ministerial Declarations (PRIMARY)
28. BRICS Brazil Presidency — Economy, finance, trade and infrastructure documents (PRIMARY)
29. BRICS Brazil Presidency — Finance Track priorities for 2025 (PRIMARY)
30. BRICS Brazil Presidency — BRICS Agriculture Working Group Ministerial Declaration (PRIMARY)